Share and Follow
The affected soaps and creams tested positive for a bacteria that can cause severe infections in vulnerable people.
WASHINGTON — DermaRite Industries, LLC has issued a voluntary recall of select lots of four over-the-counter healthcare products due to bacteria contamination.
According to the U.S. Food and Drug Administration, the recalled hand soap, cleanser and antiseptic products are contaminated with Burkholderia cepacia complex (BCC).
The recalled products include:
- DermaKleen – Antiseptic lotion soap with Vitamin E, intended for handwashing to reduce bacteria on the skin.
- DermaSarra – External analgesic cream used for temporary relief of itching from minor skin irritations, such as dry skin, insect bites, detergent exposure or sunburn.
- KleenFoam – Antimicrobial foam soap with Aloe Vera, intended for handwashing after activities like changing diapers, assisting ill individuals or before contact with someone under medical care.
- PeriGiene – Antiseptic cleanser designed for hygiene in the perineal area.
The affected products were distributed nationwide and in Puerto Rico. A full list of affected lot and reorder numbers can be found online here.


According to the FDA, BCC contamination can cause serious and potentially life-threatening infections, especially in immunocompromised individuals.
In healthy users with minor skin lesions, the bacteria may cause localized infections, but in people with weakened immune systems, infections can spread to the bloodstream, potentially leading to sepsis, a potentially life-threatening condition.


DermaRite said it has not received any reports of illness related to the recall. Consumers who have the recalled products are instructed to stop using them immediately and contact their healthcare provider if they experience any symptoms.


Customers that have questions related to the recall can contact can DermaRite at 973-569-9000 x104 or at voluntary.action@dermarite.com. Adverse reactions can also be reported to the FDA’s MedWatch program at www.fda.gov/medwatch.

